Won-Gun YUN
The Efficacy of Neoadjuvant Radiotherapy after Chemotherapy And the Optimal Interval from Radiotherapy to Surgery for Resectable And Borderline Resectable Pancreatic Cancer
13:30-13:40 / BP BO 1
The Efficacy of Neoadjuvant Radiotherapy after Chemotherapy And the Optimal Interval from Radiotherapy to Surgery for Resectable And Borderline Resectable Pancreatic Cancer
13:30-13:40 / BP BO 1
Hyeong Seok KIM
Stage-matched Prognosis Comparison between YpTNM And PTNM Stage in Pancreatic Cancer
13:40-13:50 / BP BO 2
Stage-matched Prognosis Comparison between YpTNM And PTNM Stage in Pancreatic Cancer
13:40-13:50 / BP BO 2
Jinju KIM
Impact of Internal Stent for Pancreatic Anastomosis on Long-term Pancreatic Function after Pancreatoduodenectomy
13:50-14:00 / BP BO 3
Impact of Internal Stent for Pancreatic Anastomosis on Long-term Pancreatic Function after Pancreatoduodenectomy
13:50-14:00 / BP BO 3
Sung Hyun KIM
Preoperative Fistula Risk Score (p-FRS) before Pancreatoduodenectomy Using Computed Tomography Body Composition
14:00-14:10 / BP BO 4
Preoperative Fistula Risk Score (p-FRS) before Pancreatoduodenectomy Using Computed Tomography Body Composition
14:00-14:10 / BP BO 4
Mee Joo KANG
Conditional Relative Survival Rate of Gallbladder Cancer in Korea: a Population-based Study
14:10-14:20 / BP BO 5
Conditional Relative Survival Rate of Gallbladder Cancer in Korea: a Population-based Study
14:10-14:20 / BP BO 5
Tomoaki YOH
Conversion And Salvage Surgery for Advanced / Recurrent Biliary Tract Cancer
14:20-14:30 / BP BO 6
Conversion And Salvage Surgery for Advanced / Recurrent Biliary Tract Cancer
14:20-14:30 / BP BO 6
Munseok CHOI
Impact of Adjuvant Therapy on Resected Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas : an Korean Multicenter Cohort Study
14:30-14:40 / BP BO 7
Impact of Adjuvant Therapy on Resected Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas : an Korean Multicenter Cohort Study
14:30-14:40 / BP BO 7
Xiaodong TIAN
Complement-Secreting Cancer-Associated Fibroblast Remodels the Immunosuppressive Microenvironment to Promote Pancreatic Ductal Adenocarcinoma Progression
14:40-14:50 / BP BO 8
Complement-Secreting Cancer-Associated Fibroblast Remodels the Immunosuppressive Microenvironment to Promote Pancreatic Ductal Adenocarcinoma Progression
14:40-14:50 / BP BO 8